{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:51:01Z","timestamp":1791049861227,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1479-5876-11-99","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T14:43:04Z","timestamp":1366036984000},"source":"Crossref","is-referenced-by-count":19,"title":["Serum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate\/product ratios"],"prefix":"10.1186","volume":"11","author":[{"given":"Arduino A","family":"Mangoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Zinellu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001, 69: 89-95.","journal-title":"Clin Pharmacol Ther"},{"key":"1494_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0002-9343(02)01021-5","volume":"112","author":"AA Mangoni","year":"2002","unstructured":"Mangoni AA, Jackson SH: Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002, 112: 556-565. 10.1016\/S0002-9343(02)01021-5.","journal-title":"Am J Med"},{"key":"1494_CR3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jacc.2011.05.028","volume":"58","author":"V Veeranna","year":"2011","unstructured":"Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L: Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 2011, 58: 1025-1033. 10.1016\/j.jacc.2011.05.028.","journal-title":"J Am Coll Cardiol"},{"key":"1494_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.nu.06.070186.001143","volume":"6","author":"MH Stipanuk","year":"1986","unstructured":"Stipanuk MH: Metabolism of sulfur-containing amino acids. Annu Rev Nutr. 1986, 6: 179-209. 10.1146\/annurev.nu.06.070186.001143.","journal-title":"Annu Rev Nutr"},{"key":"1494_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0021-9150(02)00205-8","volume":"165","author":"K Demuth","year":"2002","unstructured":"Demuth K, Drunat S, Girerd X, Moatti N, Paul JL, Safar M, Boutouyrie P: Homocysteine is the only plasma thiol associated with carotid artery remodeling. Atherosclerosis. 2002, 165: 167-174. 10.1016\/S0021-9150(02)00205-8.","journal-title":"Atherosclerosis"},{"key":"1494_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/HYPERTENSIONAHA.107.097386","volume":"52","author":"S Ashfaq","year":"2008","unstructured":"Ashfaq S, Abramson JL, Jones DP, Rhodes SD, Weintraub WS, Hooper WC, Vaccarino V, Alexander RW, Harrison DG, Quyyumi AA: Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension. 2008, 52: 80-85. 10.1161\/HYPERTENSIONAHA.107.097386.","journal-title":"Hypertension"},{"key":"1494_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2011.05.020","volume":"219","author":"SS Dhawan","year":"2011","unstructured":"Dhawan SS, Eshtehardi P, McDaniel MC, Fike LV, Jones DP, Quyyumi AA, Samady H: The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability. Atherosclerosis. 2011, 219: 266-272. 10.1016\/j.atherosclerosis.2011.05.020.","journal-title":"Atherosclerosis"},{"key":"1494_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0005-2760(96)00182-8","volume":"1345","author":"SM Lynch","year":"1997","unstructured":"Lynch SM, Frei B: Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim Biophys Acta. 1997, 1345: 215-221. 10.1016\/S0005-2760(96)00182-8.","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.freeradbiomed.2010.11.029","volume":"50","author":"YM Go","year":"2011","unstructured":"Go YM, Jones DP: Cysteine\/cystine redox signaling in cardiovascular disease. Free Radic Biol Med. 2011, 50: 495-509. 10.1016\/j.freeradbiomed.2010.11.029.","journal-title":"Free Radic Biol Med"},{"key":"1494_CR10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2796.1994.tb00856.x","volume":"236","author":"L Brattstrom","year":"1994","unstructured":"Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B: Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med. 1994, 236: 633-641. 10.1111\/j.1365-2796.1994.tb00856.x.","journal-title":"J Intern Med"},{"key":"1494_CR11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ajcn\/70.6.1016","volume":"70","author":"L El Khairy","year":"1999","unstructured":"El Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE: Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr. 1999, 70: 1016-1024.","journal-title":"Am J Clin Nutr"},{"key":"1494_CR12","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/ije\/dyp343","volume":"39","author":"M McEvoy","year":"2010","unstructured":"McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, Scott R, Byles J, Henry D, Ewald B: Cohort profile: The Hunter Community Study. Int J Epidemiol. 2010, 39: 1452-1463. 10.1093\/ije\/dyp343.","journal-title":"Int J Epidemiol"},{"key":"1494_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","volume":"121","author":"KM Anderson","year":"1991","unstructured":"Anderson KM, Odell PM, Wilson PW, Kannel WB: Cardiovascular disease risk profiles. Am Heart J. 1991, 121: 293-298. 10.1016\/0002-8703(91)90861-B.","journal-title":"Am Heart J"},{"key":"1494_CR14","first-page":"235","volume":"33","author":"National Vascular Disease Prevention Alliance","year":"2004","unstructured":"National Vascular Disease Prevention Alliance: Consensus statement for the prevention of vascular disease. Aust Fam Physician. 2004, 33: 235-239.","journal-title":"Aust Fam Physician"},{"key":"1494_CR15","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/elps.200305570","volume":"24","author":"A Zinellu","year":"2003","unstructured":"Zinellu A, Carru C, Galistu F, Usai MF, Pes GM, Baggio G, Federici G, Deiana L: N-methyl-D-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement. Electrophoresis. 2003, 24: 2796-2804. 10.1002\/elps.200305570.","journal-title":"Electrophoresis"},{"key":"1494_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00726-007-0022-5","volume":"36","author":"A Zinellu","year":"2009","unstructured":"Zinellu A, Sotgia S, Scanu B, Chessa R, Gaspa L, Franconi F, Deiana L, Carru C: Taurine determination by capillary electrophoresis with laser-induced fluorescence detection: from clinical field to quality food applications. Amino Acids. 2009, 36: 35-41. 10.1007\/s00726-007-0022-5.","journal-title":"Amino Acids"},{"key":"1494_CR17","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1093\/clinchem\/28.10.2121","volume":"28","author":"S Otsuji","year":"1982","unstructured":"Otsuji S, Shibata H, Umeda M: Turbidimetric immunoassay of serum C-reactive protein. Clin Chem. 1982, 28: 2121-2124.","journal-title":"Clin Chem"},{"key":"1494_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470. 10.7326\/0003-4819-130-6-199903160-00002.","journal-title":"Ann Intern Med"},{"key":"1494_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1479-5868-8-62","volume":"8","author":"TL Hart","year":"2011","unstructured":"Hart TL, Swartz AM, Cashin SE, Strath SJ: How many days of monitoring predict physical activity and sedentary behaviour in older adults?. Int J Behav Nutr Phys Act. 2011, 8: 62-10.1186\/1479-5868-8-62.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"1494_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jsams.2010.11.004","volume":"14","author":"KC Heesch","year":"2011","unstructured":"Heesch KC, Hill RL, van Uffelen JG, Brown WJ: Are Active Australia physical activity questions valid for older adults?. J Sci Med Sport. 2011, 14: 233-237. 10.1016\/j.jsams.2010.11.004.","journal-title":"J Sci Med Sport"},{"key":"1494_CR21","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/archinternmed.2010.348","volume":"170","author":"R Clarke","year":"2010","unstructured":"Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bonaa KH, Spence JD, Nygard O, Jamison R: Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010, 170: 1622-1631.","journal-title":"Arch Intern Med"},{"key":"1494_CR22","volume-title":"Cardiovasc Ther","author":"X Cheng","year":"2012","unstructured":"Cheng X: Updating the Relationship Between Hyperhomocysteinemia Lowering Therapy and Cardiovascular Events. Cardiovasc Ther. 2012, ( http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23082962 )"},{"key":"1494_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1755-5922.2011.00266.x","volume":"30","author":"B Debreceni","year":"2012","unstructured":"Debreceni B, Debreceni L: Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?. Cardiovasc Ther. 2012, 30: 227-233. 10.1111\/j.1755-5922.2011.00266.x.","journal-title":"Cardiovasc Ther"},{"key":"1494_CR24","doi-asserted-by":"publisher","first-page":"e16473","DOI":"10.1371\/journal.pone.0016473","volume":"6","author":"DS Wald","year":"2011","unstructured":"Wald DS, Morris JK, Wald NJ: Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis. PLoS One. 2011, 6: e16473-10.1371\/journal.pone.0016473.","journal-title":"PLoS One"},{"key":"1494_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0021-9150(00)00724-3","volume":"157","author":"WE van den Brandhof","year":"2001","unstructured":"van den Brandhof WE, Haks K, Schouten EG, Verhoef P: The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis. 2001, 157: 403-409. 10.1016\/S0021-9150(00)00724-3.","journal-title":"Atherosclerosis"},{"key":"1494_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1373\/49.6.895","volume":"49","author":"L El Khairy","year":"2003","unstructured":"El Khairy L, Vollset SE, Refsum H, Ueland PM: Plasma total cysteine, mortality, and cardiovascular disease hospitalizations: the Hordaland Homocysteine Study. Clin Chem. 2003, 49: 895-900. 10.1373\/49.6.895.","journal-title":"Clin Chem"},{"key":"1494_CR27","doi-asserted-by":"publisher","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","volume":"272","author":"D Steinberg","year":"1997","unstructured":"Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997, 272: 20963-20966. 10.1074\/jbc.272.34.20963.","journal-title":"J Biol Chem"},{"key":"1494_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1017\/S0007114509991565","volume":"103","author":"K Weisse","year":"2010","unstructured":"Weisse K, Brandsch C, Hirche F, Eder K, Stangl GI: Lupin protein isolate and cysteine-supplemented casein reduce calcification of atherosclerotic lesions in apoE-deficient mice. Br J Nutr. 2010, 103: 180-188. 10.1017\/S0007114509991565.","journal-title":"Br J Nutr"},{"key":"1494_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2249.2011.04519.x","volume":"167","author":"S Hasegawa","year":"2012","unstructured":"Hasegawa S, Ichiyama T, Sonaka I, Ohsaki A, Okada S, Wakiguchi H, Kudo K, Kittaka S, Hara M, Furukawa S: Cysteine, histidine and glycine exhibit anti-inflammatory effects in human coronary arterial endothelial cells. Clin Exp Immunol. 2012, 167: 269-274. 10.1111\/j.1365-2249.2011.04519.x.","journal-title":"Clin Exp Immunol"},{"key":"1494_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1357-2725(99)00138-7","volume":"32","author":"JD Finkelstein","year":"2000","unstructured":"Finkelstein JD, Martin JJ: Homocysteine. Int J Biochem Cell Biol. 2000, 32: 385-389. 10.1016\/S1357-2725(99)00138-7.","journal-title":"Int J Biochem Cell Biol"},{"key":"1494_CR31","doi-asserted-by":"publisher","first-page":"H13","DOI":"10.1152\/ajpheart.00598.2010","volume":"300","author":"RS Beard Jr","year":"2011","unstructured":"Beard RS, Bearden SE: Vascular complications of cystathionine beta-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol. 2011, 300: H13-H26. 10.1152\/ajpheart.00598.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1494_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1089\/ars.2011.4349","volume":"17","author":"LL Pan","year":"2012","unstructured":"Pan LL, Liu XH, Gong QH, Yang HB, Zhu YZ: Role of cystathionine gamma-lyase\/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?. Antioxid Redox Signal. 2012, 17: 106-118. 10.1089\/ars.2011.4349.","journal-title":"Antioxid Redox Signal"},{"key":"1494_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/BC.2009.033","volume":"390","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL: Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009, 390: 191-214.","journal-title":"Biol Chem"},{"key":"1494_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/dmrr.2261","volume":"28","author":"D Sluik","year":"2012","unstructured":"Sluik D, Beulens JW, Weikert C, van Dieren S, Spijkerman AM, van der AD, Fritsche A, Joost HG, Boeing H, Nothlings U: Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Diabetes Metab Res Rev. 2012, 28: 284-288. 10.1002\/dmrr.2261.","journal-title":"Diabetes Metab Res Rev"},{"key":"1494_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2009.12.037","volume":"210","author":"LP Breitling","year":"2010","unstructured":"Breitling LP, Grandi NC, Hahmann H, Wusten B, Rothenbacher D, Brenner H: Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis. 2010, 210: 649-655. 10.1016\/j.atherosclerosis.2009.12.037.","journal-title":"Atherosclerosis"},{"key":"1494_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2009.06.002","volume":"208","author":"OP Wojcik","year":"2010","unstructured":"Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Costa M, Chen Y: The potential protective effects of taurine on coronary heart disease. Atherosclerosis. 2010, 208: 19-25. 10.1016\/j.atherosclerosis.2009.06.002.","journal-title":"Atherosclerosis"},{"key":"1494_CR37","volume-title":"Eur J Nutr","author":"OP Wojcik","year":"2012","unstructured":"Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, Pearte C, Costa M, Chen Y: Serum taurine and risk of coronary heart disease: a prospective, nested case\u2013control study. Eur J Nutr. 2012"},{"key":"1494_CR38","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","volume":"103","author":"PM Ridker","year":"2001","unstructured":"Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001, 103: 1813-1818. 10.1161\/01.CIR.103.13.1813.","journal-title":"Circulation"},{"key":"1494_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.CIR.0000080289.72166.CF","volume":"108","author":"MA Albert","year":"2003","unstructured":"Albert MA, Glynn RJ, Ridker PM: Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003, 108: 161-165. 10.1161\/01.CIR.0000080289.72166.CF.","journal-title":"Circulation"},{"key":"1494_CR40","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.106.643114","volume":"115","author":"N Sattar","year":"2007","unstructured":"Sattar N, Murray HM, McConnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M: C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation. 2007, 115: 981-989. 10.1161\/CIRCULATIONAHA.106.643114.","journal-title":"Circulation"},{"key":"1494_CR41","doi-asserted-by":"publisher","first-page":"a3083","DOI":"10.1136\/bmj.a3083","volume":"338","author":"W de Ruijter","year":"2009","unstructured":"de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, Gussekloo J: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009, 338: a3083-10.1136\/bmj.a3083.","journal-title":"BMJ"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-11-99\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-11-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T10:52:19Z","timestamp":1595674339000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-11-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-11-99","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"article-number":"99"}}